NCT02034110 2023-08-21Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare CancersNovartisPhase 2 Completed206 enrolled 40 charts 2 FDA
NCT01829711 2020-04-08Moxetumomab Pasudotox for Advanced Hairy Cell LeukemiaMedImmune LLCPhase 3 Completed80 enrolled 32 charts 1 FDA